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Return to dialysis after renal transplantation. Which would be there is still a continuous loss of renal transplants as of
the best way? The exact moment to return to dialysis when a the first year, which has not been completely avoided
graft fails has not clearly been established. Furthermore, there with the past generation of immunosuppressive drugs.is no agreement with respect to whether the guidelines accepted
In our series, these losses suppose an average of 4% perfor patients entering dialysis for the first time are adequate for
year during the first 5 years, and between 1% and 3%this subgroup of patients with advanced renal failure, due to
the special characteristics of these patients, derived from the thereafter; these figures increase slightly if the patient
immunosuppressive medications they are taking among other has suffered an acute rejection episode (AR) (between
accompanying factors. We reviewed a group of renal transplant 2% and 5%). Isolated acute tubular necrosis (ATN) doespatients who returned to dialysis and compared them with a
not appear to influence those losses in the long term butgroup of patients entering dialysis for the first time. Patients
does have a direct influence through its association withwith chronic renal failure due to graft failure had a poorer
renal function at the time entering dialysis and a more profound AR, at least in our series. This situation, together with
anemia. Additionally, complications considered such as the the progressive increase in the number of renal trans-
number of hispital admissions during the first year after initia- plants, means that the population of transplant patientstion of dialysis were considereably higher in the group of trans-
readmitted to a dialysis program will be progressivelyplanted patients. We advocate for an earlier referral to the
greater. In fact, the loss of a functioning renal graft hasdialysis unit, a more aggressive erythropoietin therapy in the
phase of advanced renal failure due to chronic allograft ne- been, during the past year, the second cause for entry
phropathy, and in selected cases retransplantation before de- into a dialysis program in our population. Therefore, it
finitive graft loss. is necessary to consider this group of patients as a specific
subgroup among the predialysis patients given their spe-
cific characteristics and, above all, to answer the key
Over the past few years, renal graft survival has consid- question: When do we have to restart dialysis?
erably improved. In a large U.S. series published last There are no clear references in the literature with
year [1] with almost 100,000 transplants analyzed, an respect to the optimal moment to return to dialysis for
increase in the average graft life of 6 years was observed patients with a failing transplant, so the only recommen-
(and more than 8 years when those cases lost because dations available are those made for the initiation of
of death with a functioning kidney were excluded from dialysis in the population of chronic renal failure patients
the study). Similar results have also been observed in in general [2]. Classically, these recommendations were
Europe, in accordance with the Collaborative Transplant based on clinical criteria, clinical symptoms compatible
Study data: An increase of over 9 years has been achieved with uremia or fluid overload, and on biochemical crite-
since 1982. In the same way, in our population of renal ria centered on the renal function, measured by serum
transplant patients, we have observed an increase in graft creatinine, urea, and creatinine clearance (CCr). Never-survival of over 20% in the first post-transplant year, theless, there is currently a greater tendency to include
and almost 40% in the fifth post-transplant year, when more accurate methods or calculations as the average of
the past two decades are considered. urea and CCr as a more exact measure of the real glomeru-Nevertheless, despite this considerable improvement, lar filtration rate, and to apply the urea kinetic model
(weekly Kt/V) as an indirect or orientative measure of
the elimination of uremic toxins [3]. With regard to theKey words: kidney transplantation, chronic allograft nephropathy,
complications, anemia, morbimortality. figures that show the need for entry into dialysis, there is
controversy; so the U.S. opinion, represented mainly in 2002 by the International Society of Nephrology
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Table 1. Evolution of the analytical data in the group of patients
with chronic nephropathy of the implant
2 1 9 6 3
years year months months months Start
Urea mg/dL 119 129 160 169 211 249
CCr mL/m 34 33 22 21 15 9
Cur.CCr / 2 32 26 21 17 11 6
Weekly Kt/V 5.4 4.2 3.7 2.9 2.0 1.3
Hemoglobin 12.1 12.2 11.1 10.8 9.4 8.9
Abbreviations are: CCr, creatinine clearance; Weekly Kt/V, urea kinetic model.
Table 2. Percentage of patients with chronic allograft nephropathy
with analytical values above the theoretically ideal
Fig. 1. Morbidity of patients in the first years of dialysis: percentage
2 1 9 6 3 of patients admitted to hospital at least once and the average number of
years year months months months Start times admitted. Comparison between patients who return after implant
failure (Tx) (light shaded box) and those starting substitutive treatment%
for the first time (No Tx) (dark shaded box).
Urea 200 0 5 8 16 29 79
CCr 10 mL/m 3 8 13 15 41 78
Cur.CCr / 2 10 8 10 15 27 39 89
Weekly Kt/V 2 8 15 19 26 52 87 METHODS
Hemoglobin 8 0 0 4 12 16 31
One hundred and ninety-two patients who started sub-
Abbreviations are in Table 1.
stitutive therapy were analyzed. This group includes two
subgroups of patients: 70 patients with chronic allograft
nephropathy (CAN, group A), and 122 patients initiating
Table 3. Comparison of the analytical values in patients with chronic substitutive therapy for the first time (group B). Theallograft nephropathy and with chronic renal insufficiency without
whole group corresponds to all the patients enteringtransplant (CRI no tx.), at the start
or return to dialysis dialysis at our institution between January 1995 and De-
cember 2000, with clinical and analytical data availableCAN CRI no tx. P
for at least 2 years before the initiation of dialysis.
Urea mg/dL 249 214 0.018
Serum chemistry and complete blood cell count wereCCr mL/m 9 13 0.048
Cur.CCr/2 6 10 0.019 performed in all patients in every evaluation, and the
Weekly Kt/V 1.4 1.65 0.01 following parameters were specifically analyzed or calcu-
Hemoglobin 8.9 10.2 0.04 lated: Urea, serum creatinine, classical CCr (corrected
for body surface area), calculated CCr (Cockcroft-Gault
formula), urea clearance, average urea-CCr, and weekly
Kt/V of urea. Data collection was carried out on thethe DOQI Guidelines (National Kidney Foundation-
following time scheme: at the initiation of dialysis, andDialysis Outcomes Quality Initiative), recommends an
1, 3, 6, 9, 12, and 24 months before that moment.early entry: weekly Kt/V equal to or greater than 2 which
would approximately represent a CCr of 14 mL/min and Evaluation of initiation of dialysis
an average urea and CCr of 10 [4, 5]. On the other hand,
The intensity of morbidity and the mortality of thethe European criteria are more flexible and, in general,
patients was evaluated and correlated with the renaldelay the initiation of substitutive treatment somewhat
function at the moment of initiation of dialysis. For themore.
analysis of patient morbidity, the number of hospitalAs we have already mentioned above, these criteria
admissions was computed, as was the total days of hospi-are those used for patients with primary chronic renal
talization for all the patients between months 2 and 12insufficiency, not because of graft failure. So, what hap- after entering or returning to dialysis. Admissions during
pens with the second group? Are those criteria adequate the first month and those episodes secondary to vascular
for their return to dialysis? The answer to these questions access problems (both internal arteriovenous fistula or
is the reason for this current study in which we analyze central venous catheter) were excluded. Mortality rate
our experience in the following specific aspects: the bio- was analyzed by means of actuarial survival curves
chemical situation of the patients with chronic graft ne- (Kaplan-Meier).
phropathy at the time of their return to dialysis; the
comparison with the situation of patients who are start-
RESULTSing the substitutive therapy for the first time, and the
impact of these factors on morbimortality after the initia- The evolution of analytical main data on the patients
with CAN are summarized in Table 1. It shows that attion of dialysis.
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Fig. 2. Correlation between the total number of days admitted to hospital in the first year after returning to dialysis for implant failure and the
average values of urea-creatinine clearance (CCr) (A) and of weekly Kt/V of urea (B).
the start of dialysis all the average values were below tions of this return, something that has not yet happened,
the aforementioned DOQI recommendations. Table 2 at least as far as a review of the literature shows. Graft
shows the percentage of patients with values above the failure causes the patient, and sometimes the doctor, a
theoretically ideal ones. The comparison of those values feeling of failure and emotional stress (generally greater
related to renal function in groups A and B are shown than the first time) which may lead to a delay in the
in Table 3. Statistically significant differences con be return to dialysis, very often not adequately justified by
observed between both groups. the patient’s clinical and analytical situation. This fact,
With regard to morbidity, Fig. 1 shows how the pa- together with the special characteristics of this kind of
tients in group A with CAN were admitted to the hospital patient (immunosuppressive therapy, chronic inflamma-
(at least once during the first year after returning to tory state, associated pathologies, and relative resistance
dialysis) in a percentage almost double that of group B to the effect of erythropoietin) [6], among others, means
(57% vs. 29%). Also, the average number of admissions that the clinical situation could clearly be worse than in
per patient was significantly higher in group A. With those patients who are starting substitutive treatment
respect to the total number of days of hospitalization in for the first time.
the first year after entering dialysis, patients in group A In our series, patients with CAN return to dialysis
had an average of 21.1 compared with 10.2 days in the with a clearly worse analytical profile than that recom-
group B (P 0.012). When the total days of hospitaliza- mended as ideal in the DOQI guidelines [4]. So, the
tion of patients in group A was correlated with renal average urea figure is 20% greater than that recom-
functional parameters, a significant negative statistical mended, and the percentage of patients with a urea
correlation could be observed when the average of urea greater than 200 is over 75%. Also, the average urea
and CCr (Fig. 2A) and the weekly Kt/V (Fig. 2B) were and CCr are 30-40% lower that those considered idealconsidered. for starting dialysis. The analysis of the weekly Kt/V of
Patient survival after return to dialysis (group A) was
urea corroborates these results: The patients with graft
73% at 1 year, and 67% at 5 years. Those patients who
failure start dialysis with an average value of 1.4, 30%died had an average of urea-CCr that was lower than lower than that considered as the minimum for an insuf-those who were alive (5.2  4.8 vs. 8.1  5.5, P  0.02)
ficient elimination of uremic toxins. If we look at theand a weekly Kt/V of urea also lower (0.97  0.6 vs.
evolution of the analytical values, we can see how this1.5  0.7, P  0.02) on their admission to dialysis.
situation would be corrected to a large extent if this
group of patients started dialysis approximately 3 months
DISCUSSION earlier. Also, the comparison with the group of patients
who are starting substitutive treatment for the first timeThe progressive increase in the number of patients
clearly shows us that there is a difference in our attitudewho return to dialysis after a failed renal transplant
means that it is necessary to consider the clinical condi- when deciding the time to start dialysis: All the parame-
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ters studied show that it is much earlier when the patient this return took place later. It would be very advisable, in
order to prevent the possible negative impact on theirdoes not come from a failed graft.
The hemoglobin also has values well below those rec- morbimortality, to begin substitutive therapy earlier or
to perform a therapeutic intervention that would in-ommended, although in this case the cause is not only
because of the theoretical delay in returning to dialysis crease the renal function to more suitable levels. One
possibility would be growing dialysis that would takebut could be due to a state of relative ferropenia (the
patients that are still not under dialysis usually receive advantage of the renal function of the graft [8], and
another would be retransplantation of these patients be-less intravenous iron) and the very resistance itself to
the action of the erythropoietin [6]. The solution, in fore the total loss of function. The latter would also
have the advantage of being able to use kidneys with aaccordance with the European Guidelines, is the same
as for patients in pre-dialysis for the first time: treatment relatively low nephronal mass (very elderly donors, low
weight, or with a relatively high percentage of sclerosedwith EPO when the hemoglobin is lower than 11 g/L,
although, generally, in greater doses [7]. glomeruli), in the same way as a double transplant [9]. In
this situation the emotional stress of a return to dialysisThis late return to dialysis also seems to have a certain
negative impact on the morbimortality of this kind of would be avoided, and the immunosuppressive treat-
ment the patient has already taken could be utilized.patient: Both the number of admissions (excluding those
caused by vascular access problems) and the total days
Reprint requests to Dr. Manuel Arias, Nephrology Department,
of admission during the first year are significantly greater “Margues de Vadecilla” Hospital, University of Cantabria, Santander,
Spain.in patients with graft failure. There is also a significant
correlation between the total number of days of hospital-
ization and the values of the average urea and CCr and REFERENCES
the weekly Kt/V of urea, which may indicate a negative 1. Hariharan S, Jonson CP, Bresnahan BA, et al: Improved graft
survival after renal transplantation in the United States, 1998 toimpact on the clinical situation of these patients; this will
1996. N Engl J Med 342:605–613, 2000have to be confirmed with wider studies.
2. Hakim RM, Lazarus JM: Initiation of dialysis. J Am Soc Nephrol
Another worrisome circumstance is the high mortality 6:1319–1328, 1995
3. Tattersall J, Greenwood R, Farrington K: Urea kinetics andobserved after the return to dialysis, especially in the
when to commence dialysis. Am J Nephrol 15:283–289, 1995first year. This is greater than the general mortality of
4. NKF-K/DOQI: Clinical practice guidelines. Am J Kidney Dis
our patients on substitutive therapy, and one that has 30(Suppl 2):S67–S136, 1997
5. Obrador GT, Arora P, Kausz AT, et al: Level of renal functionalso been described recently in very wide series of pa-
at initiation of dialysis in the U.S. end-stage renal disease population.tients with graft failure once they have returned to dial-
Kidney Int 56:2227–2235, 1999
ysis (abstract; Meier-Kriesche, Kaplan, 2001 A Trans- 6. EDTA-ERA: European best practice guidelines for the manage-
ment of anaemia in patients with chronical renal failure. Guidelinesplant Odyssey, Istanbul, August 2001). As with the
14–16. Inadequate response to epoetin. Nephrol Dial Transplantmorbidity, we have observed that the patients who died 15(Suppl 4):43–50, 2000
had significantly greater figures of average urea and CCr 7. EDTA-ERA: European best practice guidelines for the manage-
ment of anaemia in patients with chronical renal failure. Guidelineand weekly Kt/V than those in patients who are still
9–13. Anemia management. Nephrol Dial Transplant 15 (Suppl 4):alive. The small number of patients, the same as with 33–42, 2000
the morbidity, means that these data are not conclusive 8. Keshaviah PR, Emerson TF, Kolth KD: Timely initiation of dial-
ysis: A urea kinetic approach. Am J Kidney Dis 2:344–348, 1999and that later studies are needed.
9. Andre´s A, Morales JM, Herrero JC, et al: Double versus singleIn summary, from the analysis of our series of patients renal allografts from aged donors. Transplantation 69:2000–2001,
with graft failure who returned to dialysis, we can see that 2000
